Stem Cell Trial Update:February 27, 2014

Thursday, February 27, 2014

Tisch MS Research Center of New York continues to be in active deliberation with an Institutional Review Board regarding approval of our stem cell clinical trial. We expect to have all outstanding concerns addressed in the near future and will begin study activities at that time. Please note that IRB approval and FDA approval are separate regulatory matters, and our IRB negotiations do not in any way affect our prior FDA approval. Tisch MS Research Center of New York is committed to full compliance with all laws and regulations concerning the practice of clinical research. As soon as IRB approval is obtained, notice will be posted in this space.

News Archive


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.